Avery D Posey

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Multiple Myeloma

Intellectual Disability

Top Venues

Journal for immunotherapy of cancer

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Leisha A Emens, Pedro J Romero, Ana Carrizosa Anderson, Tullia C Bruno, Christian M Capitini, Deborah Collyar, James L Gulley, Patrick Hwu, Avery D Posey, Ann W Silk, Jennifer A Wargo
Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic vision. Journal for immunotherapy of cancer 12 (6) (2024)
Ruchi P Patel, Guido Ghilardi, Yunlin Zhang, Yi-Hao Chiang, Wei Xie, Puneeth Guruprasad, Ki Hyun Kim, Inkook Chun, Mathew G Angelos, Raymone Pajarillo, Seok Jae Hong, Yong Gu Lee, Olga Shestova, Carolyn Shaw, Ivan Cohen, Aasha Gupta, Trang Vu, Dean Qian, Steven Yang, Aditya Nimmagadda, Adam E Snook, Nicholas Siciliano, Antonia Rotolo, Arati A Inamdar, Jaryse Harris, Ositadimma Ugwuanyi, Michael Wang, Alberto Carturan, Luca Paruzzo, Linhui Chen, Hatcher J Ballard, Tatiana Blanchard, Chong Xu, Mohamed Abdel-Mohsen, Khatuna Gabunia, Maria Wysocka, Gerald P Linette, Beatriz Carreno, David M Barrett, David Trent Teachey, Avery D Posey, Daniel J Powell, Christopher Tor Sauter, Stefano A Pileri, Vinodh Pillai, John Scholler, Alain H Rook, Stephen J Schuster, Stefan Klaus Barta, Patrizia Porazzi, Marco Ruella
CD5 deletion enhances the antitumor activity of adoptive T cell therapies. Science immunology 9 (97) (2024)
Leisha A Emens, Pedro J Romero, Ana Carrizosa Anderson, Tullia C Bruno, Christian M Capitini, Deborah Collyar, James L Gulley, Patrick Hwu, Avery D Posey, Ann W Silk, Jennifer A Wargo
Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic vision. Journal for immunotherapy of cancer 12 (6) (2024)
Leisha A Emens, Pedro J Romero, Ana Carrizosa Anderson, Tullia C Bruno, Christian M Capitini, Deborah Collyar, James L Gulley, Patrick Hwu, Avery D Posey, Ann W Silk, Jennifer A Wargo
Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic vision. Journal for immunotherapy of cancer 12 (6) (2024)
Oula K Dagher, Avery D Posey
Forks in the road for CAR T and CAR NK cell cancer therapies. Nature immunology 24 (12) (2023)
Mikkel Koed Møller Aasted, Aaron C Groen, John T Keane, Sally Dabelsteen, Edwin Tan, Julia Schnabel, Fang Liu, Hyeon-Gyu S Lewis, Constantine Theodoropulos, Avery D Posey, Hans Heugh Wandall
Targeting solid cancers with a cancer-specific monoclonal antibody to surface expressed aberrantly O-glycosylated proteins. Molecular cancer therapeutics (2023)
Keisuke Watanabe, M Angela Aznar, Shunichiro Kuramitsu, Mikko Siurala, Tong Da, Sangya Agarwal, Decheng Song, John Scholler, Antonia Rotolo, Avery D Posey, Alain H Rook, Paul L Haun, Marco Ruella, Regina M Young, Carl H June
Identifying highly active anti-CCR4-CAR T cells for the treatment of T-cell lymphoma. Blood advances (2023)
Ian D Ferguson, Bonell Patiño Escobar, Sami T Tuomivaara, Yu-Hsiu Tony Lin, Matthew A Nix, Kevin K Leung, Corynn Kasap, Emilio Ramos, Wilson Nieves Vasquez, Alexis Talbot, Martina Hale, Akul Naik, Audrey Kishishita, Priya Choudhry, Antonia Lopez-Girona, Weili Miao, Sandy W Wong, Jeffrey L Wolf, Thomas G Martin, Nina Shah, Scott Vandenberg, Sonam Prakash, Lenka Besse, Christoph Driessen, Avery D Posey, R Dyche Mullins, Justin Eyquem, James A Wells, Arun P Wiita
The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance. Nature communications 13 (1) (2022)
Tiffany R King-Peoples, Avery D Posey
Splitting signals drives CARs further. Nature cancer 2 (9) (2022)
Nohelly Derosiers, William Aguilar, David A DeGaramo, Avery D Posey
Sweet Immune Checkpoint Targets to Enhance T Cell Therapy. Journal of immunology (Baltimore, Md. : 1950) 208 (2) (2022)
Adham S Bear, Tatiana Blanchard, Joseph Cesare, Michael J Ford, Lee P Richman, Chong Xu, Miren L Baroja, Sarah McCuaig, Christina Costeas, Khatuna Gabunia, John Scholler, Avery D Posey, Mark H O'Hara, Anze Smole, Daniel J Powell, Benjamin A Garcia, Robert H Vonderheide, Gerald P Linette, Beatriz M Carreno
Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting. Nature communications 12 (1) (2021)